{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:17:58Z","timestamp":1761920278685},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/leu.2017.114","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T08:01:45Z","timestamp":1491552105000},"page":"2742-2751","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Constitutively active ABL family kinases, TEL\/ABL and TEL\/ARG, harbor distinct leukemogenic activities in vivo"],"prefix":"10.1038","volume":"31","author":[{"given":"A","family":"Yokota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"BFleu2017114_CR1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1126\/science.3787260","volume":"234","author":"GD Kruh","year":"1986","unstructured":"Kruh GD, King CR, Kraus MH, Popescu NC, Amsbaugh SC, McBride WO et al. A novel human gene closely related to the abl proto-oncogene. Science 1986; 234: 1545\u20131548.","journal-title":"Science"},{"key":"BFleu2017114_CR2","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1073\/pnas.87.15.5802","volume":"87","author":"GD Kruh","year":"1990","unstructured":"Kruh GD, Perego R, Miki T, Aaronson SA . The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc Natl Acad Sci USA 1990; 87: 5802\u20135806.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017114_CR3","first-page":"1899","volume":"6","author":"R Perego","year":"1991","unstructured":"Perego R, Ron D, Kruh GD . Arg encodes a widely expressed 145-kDa protein-tyrosine kinase. Oncogene 1991; 6: 1899\u20131902.","journal-title":"Oncogene"},{"key":"BFleu2017114_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/1098-2264(2000)9999:9999<1::AID-GCC1089>3.0.CO;2-1","volume":"30","author":"H van Limbergen","year":"2001","unstructured":"van Limbergen H, Beverloo HB, van Drunen E, Janssens A, Hahlen K, Poppe B et al. Molecular cytogenetic and clinical findings in EGV6\/ABL1-positive leukemia. Genes Chromosome Cancer 2001; 30: 274\u2013282.","journal-title":"Genes Chromosome Cancer"},{"key":"BFleu2017114_CR5","first-page":"34","volume":"55","author":"P Papadopoulos","year":"1995","unstructured":"Papadopoulos P, Ridge SA, Boucher DA, Stocking C, Wiedemann LM . The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 1995; 55: 34\u201338.","journal-title":"Cancer Res"},{"key":"BFleu2017114_CR6","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1128\/MCB.16.8.4107","volume":"16","author":"TR Golub","year":"1996","unstructured":"Golub TR, Goga A, Barker GF, Afar DEH, McLaughlin J, Bohlander SK et al. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol. 1996; 16: 4107\u20134116.","journal-title":"Mol Cell Biol."},{"key":"BFleu2017114_CR7","first-page":"2003","volume":"10","author":"V Brunel","year":"1996","unstructured":"Brunel V, Sainty D, Carbuccia N, Mozzicolacci M, Fernandez F, Simonetti J et al. A TEL\/ABL fusion gene on chromosome 12p13 in a case of Ph-, BCR- atypical CML. Leukemia 1996; 10: 2003.","journal-title":"Leukemia"},{"key":"BFleu2017114_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/(SICI)1098-2264(199711)20:3<299::AID-GCC11>3.0.CO;2-K","volume":"20","author":"P Andreasson","year":"1997","unstructured":"Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F et al. BCR\/ABL-negative chronic myeloid leukemia with ETV6\/ABL fusion. Genes Chromosomes Cancer 1997; 20: 299\u2013304.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2017114_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/1098-2264(2000)9999:9999<1::AID-GCC1089>3.0.CO;2-1","volume":"30","author":"H van Limbergen","year":"2001","unstructured":"van Limbergen H, Beverloo HB, van Drunen E, Janssens A, Hahlen K, Poppe B et al. Molecular cytogenetic and clinical findings in ETV6\/ABL1-positive leukemia. Genes Chromosome Cancer 2001; 30: 274\u2013282.","journal-title":"Genes Chromosome Cancer"},{"key":"BFleu2017114_CR10","first-page":"2126","volume":"95","author":"Y Iijima","year":"2000","unstructured":"Iijima Y, Ito T, Oikawa T, Eguchi M, Eguchi-Ishimae M, Kamada N, Kishi K et al. A new ETV6\/TEL partner gene ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation. Blood 2000; 95: 2126\u20132131.","journal-title":"Blood"},{"key":"BFleu2017114_CR11","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood.V94.12.4370","volume":"94","author":"G Cazzaniga","year":"1999","unstructured":"Cazzaniga G, Tosi S, Aloisi A, Giudici G, Daniotti M, Pioltelli P et al. The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13):molecular cloning of both reciprocal transcripts. Blood 1999; 94: 4370\u20134373.","journal-title":"Blood"},{"key":"BFleu2017114_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1046\/j.1365-2141.2002.03850.x","volume":"119","author":"F Griesinger","year":"2002","unstructured":"Griesinger F, Janke A, Podleschny M, Bohlander SK . Identification of an ETV6-ABL2 fusion transcript in combination with an ETV6 point mutation in a T-cell acute lymphoblastic leukaemia cell line. Br J Haematol 2002; 119: 454\u2013458.","journal-title":"Br J Haematol"},{"key":"BFleu2017114_CR13","first-page":"135","volume":"26","author":"K Kishi","year":"1998","unstructured":"Kishi K, Toba K, Azegami T, Tsukada N, Uesugi Y, Masuko M et al. Hematopoietic cytokine-dependent deifferentiation to eosinophils and neutrophils in a newly established acute promyeloytic leukemia cell laine with t(15;17). Exp Hematol 1998; 26: 135\u2013142.","journal-title":"Exp Hematol"},{"key":"BFleu2017114_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/sj.leu.2403668","volume":"19","author":"K Okuda","year":"2005","unstructured":"Okuda K, Oda A, Sato Y, Nakayama A, Fujita H, Sonoda Y et al. Signal transduction and cellular functions of the TEL\/ARG oncoprotein. Leukemia 2005; 19: 603\u2013610.","journal-title":"Leukemia"},{"key":"BFleu2017114_CR15","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1038\/sj.onc.1205544","volume":"21","author":"Y Iijima","year":"2002","unstructured":"Iijima Y, Okuda K, Tri NK, Tojo A, Setoyama M, Kruh GD et al. Transformation of Ba\/F3 cells and Rat-1 cells by ETV6\/ARG. Oncogene 2002; 21: 4374\u20134383.","journal-title":"Oncogene"},{"key":"BFleu2017114_CR16","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1182\/blood.V97.8.2440","volume":"15","author":"K Okuda","year":"2001","unstructured":"Okuda K, Weisberg E, Gilliland DG, Griffin JD . ARG tyrosine kinase activity is inhibited by STI571. Blood 2001; 15: 2440\u20132448.","journal-title":"Blood"},{"key":"BFleu2017114_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1532\/IJH97.03125","volume":"79","author":"K Okuda","year":"2004","unstructured":"Okuda K, Sato Y, Sonoda Y, Grifffin JD . The TEL\/ARG leukemia oncogene promotes viability and hyper-responsiveness to hematopoietic growth factors. Int J Hematol 2004; 79: 138\u2013146.","journal-title":"Int J Hematol"},{"key":"BFleu2017114_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0092-8674(89)90102-5","volume":"58","author":"RA Van Etten","year":"1989","unstructured":"Van Etten RA, Jackson P, Baltimore D . The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 1989; 58: 669\u2013678.","journal-title":"Cell"},{"key":"BFleu2017114_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1126\/science.256.5055.382","volume":"256","author":"ET Kipreos","year":"1992","unstructured":"Kipreos ET, Wang JY . Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 1992; 256: 382\u2013385.","journal-title":"Science"},{"key":"BFleu2017114_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1083\/jcb.124.3.325","volume":"124","author":"RA Van Etten","year":"1994","unstructured":"Van Etten RA, Fackson P, Baltimore D, Sanders MC, Matsudaira PT, Janmey PA . The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J Cell Biol 1994; 124: 325\u2013340.","journal-title":"J Cell Biol"},{"key":"BFleu2017114_CR21","first-page":"193","volume":"13","author":"B Wang","year":"1996","unstructured":"Wang B, Kruh GD . Subcellular localization of the Arg protein tyrosine kinase. Oncogene 1996; 13: 193\u2013197.","journal-title":"Oncogene"},{"key":"BFleu2017114_CR22","doi-asserted-by":"publisher","first-page":"14865","DOI":"10.1073\/pnas.251249298","volume":"98","author":"Y Wang","year":"2001","unstructured":"Wang Y, Miller AL, Mooseker MS, Koleske AJ . The Abl-related gene (Arg) nonreceptor tyrosine kinase uses two F-actin-binding domains to bundle F-actin. Proc Natl Acad Sci USA 2001; 98: 14865\u201314870.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017114_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1083\/jcb.200308055","volume":"165","author":"AL Miller","year":"2004","unstructured":"Miller AL, Wang Y, Mooseker MS, Koleske AJ . The Abl-related gene (Arg) requires its F-actin-microtubule cross-linking activity to regulate lamelipodial dynamics during fibroblast adhesion. J Cell Biol 2004; 165: 407\u2013419.","journal-title":"J Cell Biol"},{"key":"BFleu2017114_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4236\/ojbd.2013.33A005","volume":"3","author":"K Okuda","year":"2013","unstructured":"Okuda K, Hirai H . Distinct transforming activity of ABL family tyrosine kinase oncogenes is induced by their C-terminal domain. Open J Blood Dis 2013; 3: 23\u201333.","journal-title":"Open J Blood Dis"},{"key":"BFleu2017114_CR25","first-page":"136","volume":"1","author":"RG Hawley","year":"1994","unstructured":"Hawley RG, Lieu FH, Fong AZ, Hawley TS . Versatile retroviral vectors for potential us in gene therapy. Gene Ther 1994; 1: 136\u2013138.","journal-title":"Gene Ther"},{"key":"BFleu2017114_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jcp.1041400219","volume":"140","author":"T Kitamura","year":"1989","unstructured":"Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3 or erythropoietin. J Cell Physiol 1989; 140: 323\u2013334.","journal-title":"J Cell Physiol"},{"key":"BFleu2017114_CR27","first-page":"341","volume":"51","author":"N Komatsu","year":"1991","unstructured":"Komatsu N, Nakauchi H, Miwa A, Ishikawa T, Eguchi M, Moroi M et al. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 1991; 51: 341\u2013348.","journal-title":"Cancer Res"},{"key":"BFleu2017114_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1182\/blood-2013-10-534685","volume":"124","author":"R Saleh","year":"2014","unstructured":"Saleh R, Wedeh G, Herrmann H, Bibi S, Cerny-Reiterer S, Sadovnik I et al. A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection. Blood 2014; 124: 111\u2013120.","journal-title":"Blood"},{"key":"BFleu2017114_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","volume":"12","author":"J Butterfield","year":"1988","unstructured":"Butterfield J, Weiler D, Dewald G, Gleich G . Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988; 12: 345\u2013355.","journal-title":"Leuk Res"},{"key":"BFleu2017114_CR30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0301-472X(03)00260-1","volume":"31","author":"T Kitamura","year":"2003","unstructured":"Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T et al. Retrovirus-mediated gene transfer and expression cloning: Powerful tools in functional genomics. Exp Hematol 2003; 31: 1007\u20131014.","journal-title":"Exp Hematol"},{"key":"BFleu2017114_CR31","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","volume":"7","author":"S Morita","year":"2000","unstructured":"Morita S, Kojima T, Kitamura T . Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000; 7: 1063\u20131066.","journal-title":"Gene Ther"},{"key":"BFleu2017114_CR32","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/leu.2012.258","volume":"27","author":"Y Hayashi","year":"2013","unstructured":"Hayashi Y, Hirai H, Kamio N, Yao H, Yoshioka S, Miura Y et al. C\/EBP\u03b2 promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion. Leukemia 2013; 27: 619\u2013628.","journal-title":"Leukemia"},{"key":"BFleu2017114_CR33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4049\/jimmunol.131.1.282","volume":"131","author":"JN Ihle","year":"1983","unstructured":"Ihle JN, Keller J, Oroszian S, Henderson LE, Copeland TD, Fitch F et al. Biologic properties of homogeneous interleukin 3. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, P cell-stimulating factor activity, colony-stimulating factor activity and histamine-producing cell-stimulating factor activity. J Immunol 1983; 131: 282\u2013287.","journal-title":"J Immunol"},{"key":"BFleu2017114_CR34","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1074\/mcp.M400055-MCP200","volume":"3","author":"Q Tian","year":"2004","unstructured":"Tian Q, Stepaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ et al. Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol Cell Proteomics 2004; 3: 960\u2013969.","journal-title":"Mol Cell Proteomics"},{"key":"BFleu2017114_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/32190","volume":"392","author":"CS Lantz","year":"1998","unstructured":"Lantz CS, Goesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC et al. Role for interleukin-3 in mast cell and basophil development and in immunity to parasites. Nature 1998; 392: 90\u201393.","journal-title":"Nature"},{"key":"BFleu2017114_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1084\/jem.174.1.125","volume":"174","author":"M Tsai","year":"1991","unstructured":"Tsai M, Shih LS, Newlands GFJ, Takeishi T, Langley KE, Sebo KM et al. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry and protease phenotype. J Exp Med 1991; 174: 125\u2013131.","journal-title":"J Exp Med"},{"key":"BFleu2017114_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0145-2126(01)00030-3","volume":"25","author":"KF Austin","year":"2001","unstructured":"Austin KF, Boyce JA . Mast cell lineage development and phenotypic regulation. Leuk Res 2001; 25: 511\u2013518.","journal-title":"Leuk Res"},{"key":"BFleu2017114_CR38","first-page":"241","volume":"415","author":"M Arock","year":"2008","unstructured":"Arock M, Le Nours A, Malbec O, Daeron M . Ex vivo and in vitro primary mast cells. Methods Mol Biol 2008; 415: 241\u2013254.","journal-title":"Methods Mol Biol"},{"key":"BFleu2017114_CR39","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1182\/blood-2001-12-0244","volume":"99","author":"RP Million","year":"2002","unstructured":"Million RP, Aster J, Gilliland GD, Van Etten RA . The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice. Blood 2002; 99: 4568\u20134577.","journal-title":"Blood"},{"key":"BFleu2017114_CR40","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Li Y, Payne\u2010Turner D, Harvey RC, Yang Y-L, Pei D et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 2014; 371: 1005\u20131015.","journal-title":"N Engl J Med"},{"key":"BFleu2017114_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrc3563","volume":"13","author":"EK Greuber","year":"2013","unstructured":"Greuber EK, Smith-Pearson P, Wang J, Pendergast AM . Role of ABL family kinases in cancer: from leukemia to solid tumours. Nature Rev Cancer 2013; 13: 559\u2013571.","journal-title":"Nature Rev Cancer"},{"key":"BFleu2017114_CR42","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1158\/0008-5472.CAN-06-0734","volume":"66","author":"D Srinivasan","year":"2006","unstructured":"Srinivasan D, Platter R . Activation of Abl tyrosine kinase promotes invasion of aggressive breast cancer cells. Cancer Res 2006; 66: 5648\u20135655.","journal-title":"Cancer Res"},{"key":"BFleu2017114_CR43","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1038\/onc.2012.284","volume":"32","author":"H Gil-Henn","year":"2013","unstructured":"Gil-Henn H, Patsialou A, Wang Y, Warren MS, Condeelis JS, Koleske AJ . Arg\/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo. Ocogene 2013; 32: 2622\u20132630.","journal-title":"Ocogene"},{"key":"BFleu2017114_CR44","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1172\/JCI37127","volume":"119","author":"ML Sos","year":"2009","unstructured":"Sos ML, Michel K, Zander T, Weiss J, Frommolt P, Peifer M et al. Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest 2009; 119: 1727\u20131740.","journal-title":"J Clin Invest"},{"key":"BFleu2017114_CR45","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/onc.2011.361","volume":"31","author":"SS Ganguly","year":"2012","unstructured":"Ganguly SS, Fiore LS, Sims JT, Friend JW, Srinivasan D, Thacker MA et al. c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression. Oncogene 2012; 31: 1804\u20131816.","journal-title":"Oncogene"},{"key":"BFleu2017114_CR46","doi-asserted-by":"publisher","first-page":"27230","DOI":"10.1074\/jbc.M804520200","volume":"283","author":"A Shimizu","year":"2008","unstructured":"Shimizu A, Mammoto A, Italiano JE, Pravda E, Dudley AC, Ingber DE et al. ABL2\/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells. J Biol Chem 2008; 283: 27230\u201327238.","journal-title":"J Biol Chem"},{"key":"BFleu2017114_CR47","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","volume":"112","author":"DD Metcalfe","year":"2008","unstructured":"Metcalfe DD . Mast cells and mastcytosis. Blood 2008; 112: 946\u2013956.","journal-title":"Blood"},{"key":"BFleu2017114_CR48","doi-asserted-by":"publisher","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","volume":"92","author":"H Nagata","year":"1995","unstructured":"Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560\u201310564.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017114_CR49","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ng0396-312","volume":"12","author":"BJ Longley","year":"1996","unstructured":"Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG et al. Somatic c-KIT activating mutation in urticria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996; 12: 312\u2013314.","journal-title":"Nat Genet"},{"key":"BFleu2017114_CR50","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3324\/haematol.2013.095133","volume":"99","author":"K Hanssens","year":"2014","unstructured":"Hanssens K, Brenet F, Agopian J, Georgin-Lavialle S, Damaj G, Cabaret L et al. SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes. Haematologica 2014; 99: 830\u2013835.","journal-title":"Haematologica"},{"key":"BFleu2017114_CR51","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/leu.2009.37","volume":"23","author":"A Tefferi","year":"2009","unstructured":"Tefferi A, Levine RL, Lim KH, Abdel-Wahab O, Lasho TL, Patel J et al. Frequent TET2 mutations in systemic mastocytosis: clinical, KIT816V and FIP1L1-PDGFRA correlates. Leukemia 2009; 23: 900\u2013904.","journal-title":"Leukemia"},{"key":"BFleu2017114_CR52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.V88.3.995.995","volume":"88","author":"H Kitayama","year":"1996","unstructured":"Kitayama H, Tsujimura T, Matsumura I, Oritani K, Ikeda H, Ishikawa J et al. Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase. Blood 1996; 88: 995\u20131004.","journal-title":"Blood"},{"key":"BFleu2017114_CR53","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20050807","volume":"202","author":"JP Zappulla","year":"2005","unstructured":"Zappulla JP, Dubreuil P, Desbois S, Letard S, Hamouda NB, Daeron M et al. Mastocytosis in mice expressing human kit receptor with the activating Asp816Val mutation. J Exp Med 2005; 202: 1635\u20131641.","journal-title":"J Exp Med"},{"key":"BFleu2017114_CR54","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0092-8674(93)80044-F","volume":"74","author":"F Grignani","year":"1993","unstructured":"Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Fagioli M et al. The acute promyelocytic leukaemia specific PML-RAR\u03b1 fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 1993; 74: 423\u2013431.","journal-title":"Cell"},{"key":"BFleu2017114_CR55","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood.V85.5.1313.bloodjournal8551313","volume":"85","author":"H Poirel","year":"1995","unstructured":"Poirel H, Radford-Weiss I, Rack K, Troussard X, Veil A, Valensi F et al. Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias. Blood 1995; 85: 1313\u20131322.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2017114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2017114","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/leu.2017.114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/leu2017114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T01:37:38Z","timestamp":1692754658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2017114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["BFleu2017114"],"URL":"https:\/\/doi.org\/10.1038\/leu.2017.114","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]},"assertion":[{"value":"25 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}